3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 37.60
+0.60 (1.62%)
Aug 17, 2026, 1:43 PM CST
3D Global Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 159.19 | 206.74 | 265.69 | 20.63 | 13.64 | 11.08 |
Revenue Growth | -23.00% | -22.19% | 1187.67% | 51.23% | 23.19% | -16.48% |
Gross Profit Gross Profit Growth | 105.86 | 148.41 | 174.51 | 5.27 | 2.72 | 1.8 |
Operating Income Operating Income Growth | -6.15 | 41.45 | 88.49 | -62.85 | -66.29 | -62.21 |
Net Income Net Income Growth | 14.2 | 66.53 | 91.7 | -57.95 | -67.09 | -59.71 |
Earnings Per Share EPS Growth | 0.18 | 0.84 | 1.30 | -1.03 | -1.22 | -1.11 |
EPS Growth | -78.60% | -35.38% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 147.39 | 147.39 | 134.24 | 20.63 | 13.64 | 11.08 |
China China Growth | - | - | 108.74 | - | - | - |
United State United State Growth | 59.34 | 59.34 | 22.7 | - | - | - |
Total Total Growth | 206.74 | 206.74 | 265.69 | 20.63 | 13.64 | 11.08 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 497.11 | 477.25 | 703.86 | 166.02 | 208.43 | 233.17 |
Total Debt Total Debt Growth | 45.16 | 48.66 | 84.76 | 10.38 | 16.75 | 21.31 |
Net Cash (Debt) Net Cash Growth | 451.95 | 428.59 | 619.1 | 155.64 | 191.68 | 211.87 |
Net Cash Growth | 5.45% | -30.77% | 297.78% | -18.80% | -9.53% | -17.22% |
Net Cash Per Share Net Cash Per Share Growth | 5.71 | 5.41 | 8.75 | 2.77 | 3.49 | 3.93 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 65.93 | 110.91 | 19.65 | -31.61 | -34.49 | -35.99 |
Capital Expenditures CapEx Growth | -12.91 | -6.16 | -4.74 | -0.78 | -0.85 | -2.86 |
Free Cash Flow Free Cash Flow Growth | 53.02 | 104.74 | 14.91 | -32.39 | -35.33 | -38.85 |
Free Cash Flow Growth | -49.38% | 602.50% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.50% | 71.79% | 65.68% | 25.56% | 19.91% | 16.28% |
Operating Margin | -3.86% | 20.05% | 33.31% | -304.62% | -485.87% | -561.71% |
Pretax Margin | 12.61% | 25.30% | 36.16% | -285.54% | -609.35% | -550.49% |
Profit Margin | 8.92% | 32.18% | 34.52% | -280.87% | -491.73% | -539.10% |
FCF Margin | 33.30% | 50.67% | 5.61% | -156.99% | -258.98% | -350.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.530 |
Dividend Per Share Growth | 0% | -81.13% | - |
Dividend Yield | 0.27% | 0.21% | 0.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 205.84 | 56.51 | 55.95 | - | - | - |
P/FCF Ratio | 53.72 | 35.90 | 344.12 | - | - | - |
PS Ratio | 17.89 | 18.19 | 19.31 | 52.74 | 109.79 | 193.46 |